Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration enables selective binding to specific enzyme active sites, enhancing drug efficacy and reducing off-target effects. Commonly employed in the manufacture of investigational oncology compounds where stereochemistry plays a critical role in biological activity. Also utilized in the preparation of fluorinated analogs to improve metabolic stability and bioavailability in drug candidates.